Bioject Medical Technologies Inc. (BJCT) - Product Pipeline Analysis, 2014 Update

Date: August 6, 2014
Pages: 27
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: BE32FABD953EN
Leaflet:

Download PDF Leaflet

Bioject Medical Technologies Inc. (BJCT) - Product Pipeline Analysis, 2014 Update
Summary

Bioject Medical Technologies Inc. (Bioject) is a medical device company. It undertakes the development of needle-free injection therapies to improve the outcome of the administration of liquid medications; pharmaceuticals; vaccines; and biologics. The company develops its products based on its proprietary technology that works by forcing liquid medication at high speed through a tiny orifice held against the skin. Bioject categorizes its products under four groups, namely, Biojector 2000 needle free injection system, ZetaJet system, drug reconstitution system, and needle-free vial adapters. It also develops inexpensive, pre-filled, disposable injection systems in collaboration with its partners. Bioject’s research and development (R&D) activities are focused on the development of DNA-based vaccines and medications. The company markets its products to life sciences market in the Europe Middle East and Africa, Asia Pacific, and North America through an extensive network of distributors. Bioject is headquartered in Tigard, Oregon, the US.

Bioject seeks to commercialize its products through licensing partners on a global basis. The company envisages building its position through internal development, partnerships and strategic collaboration. In line with its strategy, Bioject recently received the Australian Register of Therapeutic Goods Certificate for the Biojector needle-free injection management system (Biojector 2000), the vial transfer spike, and the Bioject ZetaJet needle-free injection therapy system through its local distributor in the region, Meditrend International.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Bioject Medical Technologies Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Bioject Medical Technologies Inc. Company Snapshot
Bioject Medical Technologies Inc. Company Overview
Key Information
Bioject Medical Technologies Inc. Pipeline Products and Clinical Trials Overview
Bioject Medical Technologies Inc. – Pipeline Analysis Overview
Business Description
Key Facts
Bioject Medical Technologies Inc. - Major Products and Services
Bioject Medical Technologies Inc. Pipeline Products by Development Stage
Bioject Medical Technologies Inc. Pipeline Products Overview
Adapter For Biojector Syringe
Adapter For Biojector Syringe Product Overview
Iject Pre-Filled Syringe
Iject Pre-Filled Syringe Product Overview
Iject R Pre-Filled Syringe
Iject R Pre-Filled Syringe Product Overview
Intradermal Pen Injector
Intradermal Pen Injector Product Overview
Jupiter Jet
Jupiter Jet Product Overview
Mega Jet
Mega Jet Product Overview
Multi-Port Orifices
Multi-Port Orifices Product Overview
Bioject Medical Technologies Inc. - Key Competitors
Bioject Medical Technologies Inc. - Key Employees
Bioject Medical Technologies Inc. - Key Employee Biographies
Bioject Medical Technologies Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Bioject Medical Technologies Inc., Recent Developments
May 12, 2014: Bioject announces the appointment of a distributor for China
Apr 22, 2014: Bioject Adds To Its Global Distribution Network
Jan 22, 2014: Bioject's Distributor Meditrend International Receives Australian Device Registration
Oct 30, 2013: Bioject Enters Into Distribution Agreement With FlashMed In Ecuador for Biojector 2000 needle-free injection system
Oct 30, 2013: Bioject Enters Into Distribution Agreement With FlashMed In Ecuador for Bioject ZetaJet
Oct 23, 2013: Bioject Enters Into Agreement With Fondaco PTE LTD For Distribution Of Full Line Of Needle Free Injection Devices In Asia
Feb 11, 2013: Bioject Reports Revenue Of $2m In 2012
Jul 20, 2012: Bioject Medical Technologies Reports Q4 2011 Results
Jul 20, 2012: Bioject Medical Technologies Reports Revenues Of $1m In Q1 2012
Nov 10, 2011: Bioject Announces Senior Management Changes
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Bioject Medical Technologies Inc., Key Facts
Bioject Medical Technologies Inc. Pipeline Products and Clinical Trials Overview
Bioject Medical Technologies Inc. Pipeline Products by Equipment Type
Bioject Medical Technologies Inc., Key Facts
Bioject Medical Technologies Inc., Major Products and Services
Bioject Medical Technologies Inc. Number of Pipeline Products by Development Stage
Bioject Medical Technologies Inc. Pipeline Products Summary by Development Stage
Adapter For Biojector Syringe - Product Status
Adapter For Biojector Syringe - Product Description
Iject Pre-Filled Syringe - Product Status
Iject Pre-Filled Syringe - Product Description
Iject R Pre-Filled Syringe - Product Status
Iject R Pre-Filled Syringe - Product Description
Intradermal Pen Injector - Product Status
Intradermal Pen Injector - Product Description
Jupiter Jet - Product Status
Jupiter Jet - Product Description
Mega Jet - Product Status
Mega Jet - Product Description
Multi-Port Orifices - Product Status
Multi-Port Orifices - Product Description
Bioject Medical Technologies Inc., Key Employees
Bioject Medical Technologies Inc., Key Employee Biographies
Bioject Medical Technologies Inc., Other Locations

LIST OF FIGURES

Bioject Medical Technologies Inc. Pipeline Products by Equipment Type
Bioject Medical Technologies Inc. Pipeline Products by Development Stage
Skip to top


Ask Your Question

Bioject Medical Technologies Inc. (BJCT) - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: